Skip to main content
OpenTrials
Completed

NCT Number: NCT01661504

Evaluating Violence Against Women Screening in Mexico

The overall goal of this proposed study is to develop the state of knowledge in the area of gender-based violence and reproductive health by conducting a randomized controlled trial to improve the health care provider's capacity to screen for intimate partner violence and to mitigate associated risk among women health clinic patrons of reproductive age (ages18-44) with recent experiences of physical or sexual partner violence in Mexico City and its surrounding area.

The specific research objectives are as follows:

1. To increase mid-level health care providers' capacity to identify Intimate Partner Violence (IPV) and assist women with risk mitigation 2. Utilizing a randomized controlled trial, to assess the impact of an enhanced health care worker screening and counselling program on (a) past year severe IPV (sexual or physical), including severe IPV; (b) reproductive coercion (c) use of community-based resources and safety planning; and (d) quality of life; versus minimum standard of care 3. To qualitatively examine which programmatic components may serve as mechanisms for observed changes stated in the second objective 4. To synthesize study findings and a) create recommendations for clinic-based intervention programs to address IPV in low and middle income countries and b) disseminate information as reports, presentation, and peer-reviewed publications

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Health Clinics associated with Ministry of Health in Mexico City

Mexico City, Mexico

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ages 18-44
  • Currently in heterosexual relationship with a male partner
  • Responds in affirmative to past year sexual or physical violence

Exclusion criteria

  • Cognitive impairment (slurred speech, inability to follow directions)
  • Seeking treatment for life threatening emergency care
  • Intends to relocate within 2 years.

Treatment and study plan

Integrated Screening

Behavioral

The intervention arm will consist of the following components (described in detail below): a) integrated IPV/Sexual and Reproductive Health Screening, b) supportive care, c) safety planning and harm reduction counseling, d) supported referrals, e) booster counseling sessions

Primary outcomes

  1. Change in Intimate Partner Violence Victimization from Baseline

    Time frame: 12 months

    Participants will be followed up at 3 months and at 15 months post-baseline to assess intimate partner violence victimization as measured by an adapted Conflict Tactics Scale - 2. This will allow for a 12 month follow-up from the booster counseling session in the intervention group which occurs at 3 months post-baseline.

Secondary outcomes

  1. Change in Quality of Life Score

    Time frame: past month

  2. Change in Use of Community Resources

    Time frame: 12 months

    Adapted Community Resources Checklist

  3. Change in Safety Planning

    Time frame: 12 Months

    Adapted Safety Behavior Checklist

  4. Change in Reproductive Coercion

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Innovations for Poverty Action
  • Mexican National Institute of Public Health

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 9, 2012
Registry last updated
Sep 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.